Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Aldeyra Therapeutics, Inc. | d105518dex312.htm |
| EX-32.1 - EX-32.1 - Aldeyra Therapeutics, Inc. | d105518dex321.htm |
| EX-31.1 - EX-31.1 - Aldeyra Therapeutics, Inc. | d105518dex311.htm |
| EX-10.24 - EX-10.24 - Aldeyra Therapeutics, Inc. | d105518dex1024.htm |
| EX-10.23 - EX-10.23 - Aldeyra Therapeutics, Inc. | d105518dex1023.htm |
| 10-K - 10-K - Aldeyra Therapeutics, Inc. | d105518d10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Aldeyra Therapeutics, Inc.
Lexington, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-206539) and Form S-8 (Nos. 333-196674 and 333-203076) of Aldeyra Therapeutics, Inc. of our report dated March 30, 2016, relating to the financial statements of Aldeyra Therapeutics, Inc., which appears in this Annual Report on Form 10-K for the year ended December 31, 2015.
/s/ BDO USA, LLP
Boston, Massachusetts
March 30, 2016